Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
BNTC
#2504
Benitec Biopharma Inc. Common Stock
10.900
0
-0.05%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.05%
Monthly Change
-12.03%
6 month change
-34.38%
Year Change
-34.38%
Previous Close
10.905
0
Open
10.900
0
Bid
Ask
Low
10.900
0
High
10.900
0
Volume
21
Markets
US Stock Market
Healthcare
BNTC
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
TTM
Key stats
Total common shares outstanding
25.6 M
26.25 M
33.86 M
34.35 M
—
Valuation ratios
Enterprise value
229.46 M
209.43 M
380.59 M
273.95 M
1.09 B
Price to earnings ratio
-20.33
-11.14
-12.09
-12.36
-55.92
Price to sales ratio
—
507.36
-1 553.57
-1 491.56
—
Price to cash flow ratio
-7.79
-17.96
-19.05
-28.68
-73.48
Price to book ratio
0.55
4.35
1.29
1.17
7.36
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.09
0.09
0.06
0.33
Return on equity %
0.1
0.09
0.1
0.06
0.35
Return on invested capital %
—
—
—
—
—
Gross margin %
—
100
—
—
—
Operating margin %
—
-4 581.35
—
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
-2 692.66
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
14.8
54.67
46.95
67.69
184.12
Inventory turnover
—
—
—
—
—
Asset turnover
0
-0
0
0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.08
0.23
0.08
0.08
0.47
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
2.68
2.7
2.28
4.11
11.77
Net current asset value per share
2.69
2.72
2.29
4.12
11.83
Tangible book value per share
2.53
2.69
2.25
4.08
11.54
Working capital per share
2.51
2.67
2.24
4.06
11.49
Book value per share
2.53
2.69
2.25
4.08
11.54
News
Benitec BioPharma : notation maintenue après données sur thérapie génique
Benitec BioPharma stock rating maintained on gene therapy data
Benitec présentera les résultats de l’étude sur la thérapie génique BB-301 en mars
Benitec to present BB-301 gene therapy study results in March
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade
Citizens maintient sa note "Market Outperform" sur l’action Benitec BioPharma
Citizens reiterates Market Outperform rating on Benitec BioPharma stock
Benitec BioPharma maintient sa note d’achat chez TD Cowen grâce à de solides données sur l’OPMD
Benitec BioPharma stock maintains Buy rating at TD Cowen on strong OPMD data
Baird maintient sa note Surperformance sur l’action Benitec BioPharma avec un objectif de 30€
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target
La thérapie génique de Benitec montre des résultats durables chez les patients atteints d’OPMD